Selling a Company to an ESOP: A Practical Guide

Document type: Guide Practice area: Corporate — Employee Benefits Jurisdiction: United States (federal) Last reviewed: 5 September 2026

Who this is for

A closely held company owner considering an ESOP, and the counsel advising them — company counsel, seller's counsel, or the lawyer who will have to explain later why the process looked the way it did.

Our example is Thornbury Instrument, a 210-employee manufacturer of laboratory balances in Rockford, founded by Augusto Thornbury-Vale, now 68, who holds 92% of the stock. His general counsel is Ines Vandeleur-Achebe.

The organizing principle: every question in an ESOP transaction reduces to whether the plan paid no more than fair market value, determined in good faith by a prudent trustee. Structure the process to make that answer provable, and the rest follows.

Step 1 — Answer the feasibility question honestly, before anything else

Model three cases, not one: management's plan, a base case, and — the one that decides it — a downturn case calibrated to the worst two-year period in the company's own history. If the downturn case breaches covenants, the leverage is too high, whatever the base case shows.

Then ask the questions the model does not answer:

Is the cash flow the right kind? Stable, recurring, diversified revenue supports leverage. Lumpy project revenue, heavy working capital swings, or top-three customer concentration above roughly a third does not.
Can the company fund debt service, plan contributions, and capital expenditure simultaneously? Contributions repaying the internal loan are cash out, deductible under 26 U.S.C. § 404(a)(9) but still cash. Companies that must reinvest to stay competitive frequently cannot do both, and it shows up in year four as deferred maintenance.
Will the business survive the owner's departure? If revenue depends on the seller's relationships, the projections behind the valuation are wrong and the employees will bear it. Name the customers who would leave.
Is there a management team and a functioning board? An ESOP has no controlling shareholder to intervene.
What does the repurchase obligation look like in twenty years? Model it now.

Watch who is running the analysis. A feasibility study prepared by the firm earning a success fee should be read with that in mind. Consider an independent look; the trustee will run its own regardless.

Thornbury's downturn case supported $38 million with covenant headroom; management's plan implied $47 million. That spread framed the entire transaction, and knowing it early prevented a negotiation built on a number the company could not service.

Step 2 — Decide whether an ESOP is the right exit

Make the comparison explicit and put it in writing to the seller.

What an ESOP does better. Liquidity at fair market value without a competitor diligencing the customer list. Section 1042 gain deferral for a C corporation seller, frequently worth more than a price premium. Continuity of place, people, and management. A tax-exempt operating structure if the company elects S status after closing. And a genuine employee benefit, which for many sellers is the actual motive.

What it does worse. The price is fair market value, not a strategic premium — a synergistic buyer can pay more, sometimes much more. The company takes on real debt. It acquires a permanent repurchase obligation. It becomes subject to ERISA. Transaction costs are meaningful. And the seller's liquidity is often deferred into a subordinated note secured by nothing but the business just sold.

When it does not work. Volatile or thin cash flow. Heavy customer concentration. A business dependent on the departing owner. A seller who wants the maximum number.

Deliverable: a written comparison, signed off by the seller. ESOPs are promoted energetically, and a seller who understands only the tax deferral has not been advised.

Step 3 — Build the transaction team, with clean roles

Role confusion is the most common defect in these transactions and the easiest to avoid.

Company counsel represents the company: plan drafting, corporate steps, and advising the board in its capacity as appointing fiduciary — itself a fiduciary role.

Seller's counsel represents the seller, whose interest in the highest defensible price is legitimate and adverse to the plan.

Trustee's counsel — a separate firm, with no prior relationship to the seller — represents the trustee, whose duty runs solely to participants under 29 U.S.C. § 1104.

The appraiser is retained by, and reports to, the trustee. An appraisal commissioned by the company or the seller may inform expectations; it cannot support the adequate consideration determination.

A financial advisor to the trustee provides the fairness opinion where the transaction warrants one.

What must not happen: the founder's long-time lawyer drafting the plan, advising the board, and negotiating for the seller; an advisor originating the deal, writing the feasibility study, recommending the trustee, and earning a success fee; an appraiser who has valued the company for the seller's estate plan for a decade now valuing it for the plan.

Tell the seller why the fees are higher. The clean structure costs more and is what stands between the company — which the employees will own — and a decade of litigation.

Step 4 — Select the trustee, and give up control of the process

The board appoints the trustee, with the seller recused. For a transaction of any size this means an institutional independent trustee, retained for the transaction, which then selects its own counsel and its own appraiser through a documented process.

Why the seller must not choose. Section 1106 prohibits a fiduciary from causing the plan to engage in a sale with a party in interest and from dealing with plan assets in his own interest. The transaction is lawful only through the exemption in § 1108(e), whose condition is adequate consideration as defined in 29 U.S.C. § 1002(18) — fair market value determined in good faith by the trustee. A trustee the seller selected, advised by an appraiser the seller chose, has not made an independent determination and the exemption is at risk.

Diligence the trustee. Institutional capacity, ESOP-specific experience, insurance, the individuals who will actually do the work, and its process. Ask how many transactions it has declined.

Then step back. The seller's counsel does not attend the trustee's deliberations, does not select the appraiser, and does not receive drafts of the valuation. This feels wrong to sellers and it is the single most protective feature of the transaction.

Step 5 — Diligence and valuation

The trustee runs diligence. Financial, legal, operational, customer concentration, key person risk, environmental, litigation, and employment. The company will experience this as a buyer's diligence, because it is one.

The projections are the centerpiece. Management projections drive the valuation, and a trustee that accepts them without testing has not been prudent. Expect — and prepare for — these questions: what did last year's projection say, and what actually happened? What is the ten-year historical growth rate against the projected rate? What supports the assumed margin expansion? Which customers are in the pipeline, and are they under contract?

Thornbury's diligence produced two findings that changed the price: the top three customers were 44% of revenue, not the 36% presented; and the five-year plan assumed 6.5% growth against a ten-year history of 2.4%.

The valuation. Standard methodologies — discounted cash flow, guideline public company, guideline transaction — with the ESOP-specific overlays: control versus minority basis depending on what the plan acquires; marketability discount adjusted for the repurchase obligation and the put right; treatment of the transaction debt; the dilutive effect of any warrants; and the treatment of the S corporation tax benefit if a conversion will follow.

What the seller should and should not do. Provide complete information promptly. Correct the record where management has been optimistic. Do not pressure the appraiser, do not ask for drafts, and do not communicate the seller's price expectation to the valuation firm. Every one of those becomes an exhibit.

Step 6 — Negotiate, and make sure the file shows it

A trustee that accepts the asking price has not negotiated, and a transaction with no negotiation history is precisely the pattern the Department of Labor looks for first.

Expect a real spread. The trustee's opening position will reflect its diligence findings, and it will be below the seller's expectation. Thornbury's advisor had prepared him for $47 million; the trustee opened at $36 million.

Negotiate the whole package, not just the number. Price, the mix of bank debt and seller notes, the seller note's rate and amortization, subordination terms, warrant coverage and strike, board composition after closing, the seller's continuing role and compensation, non-competition, and indemnification.

The seller's counsel's job here is expectation management. The number the seller was told to expect came from an advisor with a success fee; the number the trustee can pay comes from a fiduciary whose duty runs to employees. Explain this before the first offer, not after.

Thornbury closed at $41.5 million, with the reduction from the original expectation attributable to the concentration finding and the projection reset. Vandeleur-Achebe's note in the file: "The $5.5 million we gave up is the reason nobody has ever asked us about this transaction."

Document everything. The trustee's file should show the opening position, the exchanges, the analysis behind each movement, and the basis for the final determination. So should the company's.

Step 7 — Structure the financing, and watch the warrants

The layers. Senior bank debt, sized by the lender's own credit analysis — a useful independent check on feasibility. Seller notes for the balance, subordinated, at a stated rate. And, commonly, warrants to the seller to bring the blended return to a market level for subordinated risk.

Warrants require care for two reasons.

First, valuation. A warrant transfers future equity value back to the seller. If it is too generous, the plan has effectively paid more than the stated price, which is an adequate consideration problem. The trustee's appraiser must value the warrants and account for them in the price.

Second, and more dangerous: 26 U.S.C. § 409(p). For an S corporation ESOP, warrants are synthetic equity, and § 409(p) prohibits "nonallocation years" in which disqualified persons hold too large a share of the deemed-owned stock including synthetic equity. The consequences of a nonallocation year are severe, including excise tax and potential loss of the structure.

Run the § 409(p) analysis BEFORE the warrant terms are finalized, not after. This is the sequencing error that most often requires unwinding an agreed deal point.

Also structure: the internal loan terms and amortization schedule, which determine how quickly shares are released to participants; the contribution schedule, sized to service the internal loan within the deduction limits of 26 U.S.C. § 404(a)(9); and any refinancing flexibility.

Step 8 — The tax elections

Section 1042 for the seller. A C corporation seller may elect nonrecognition of gain on a sale to an ESOP if the plan owns at least 30% immediately after the sale, the seller held the securities at least three years, and the seller reinvests in qualified replacement property within the period beginning three months before and ending twelve months after the sale.

Practical requirements: the company must be a C corporation at closing (so a company already taxed as an S corporation must revoke the election, with timing and consequences to model); the seller must identify a qualified replacement property strategy in advance with an investment advisor; the statement of election and the consent must be filed correctly; and allocation restrictions apply to the seller and related persons, which affects who benefits under the plan.

The S corporation conversion after closing. An ESOP is a tax-exempt shareholder, so a 100% ESOP-owned S corporation pays essentially no federal income tax on operating income. This is the most powerful feature of the structure. Model the built-in gains consequences of converting from C to S, and confirm the § 409(p) analysis holds post-conversion with all synthetic equity included.

Deductions. Contributions applied to repay the internal loan are deductible under § 404(a)(9), including — within limits — amounts applied to principal.

Coordinate the elections in sequence: C corporation at closing → § 1042 election → S election effective for a later year → § 409(p) monitoring thereafter. Getting the order wrong forfeits the deferral or triggers the anti-abuse rule.

Step 9 — Close, and set up what runs afterward

At closing: the plan and trust documents executed; the trustee appointed and its engagement documented; the stock purchase agreement, internal and external loan documents, and pledge agreements signed; the § 1042 statement of election prepared; the board reconstituted as agreed; and the seller's continuing role papered.

Immediately after closing, put in place the things that are easy now and hard later:

A written map of fiduciary roles: who is a fiduciary, for what function, appointed by whom, monitored how. This is the document everyone reaches for when a claim arrives.
Insurance confirmed: an ERISA fidelity bond under 29 U.S.C. § 1112, which is mandatory and protects the plan against fraud or dishonesty; and separately fiduciary liability insurance, which protects fiduciaries against breach claims. Companies routinely believe they have both when they have one.
Indemnification checked against 29 U.S.C. § 1110, which voids provisions purporting to relieve a fiduciary of liability. Employer indemnification is generally permitted; plan indemnification is not.
A repurchase obligation study, commissioned now rather than in year ten.
The annual calendar: independent appraisal under 26 U.S.C. § 401(a)(28)(C), Form 5500, coverage and nondiscrimination testing, § 409(p) testing, participant statements, committee meetings with minutes.

Step 10 — Tell the employees the truth

The gap between "you now own the company" and what a participant actually holds is the largest source of dissatisfaction in ESOP companies, and it is entirely avoidable.

Say what a participant receives: an account in a retirement plan, credited with shares as the internal loan amortizes, vesting on the plan's schedule, distributable on separation at the value fixed by the annual independent appraisal, with a put right requiring the company to buy the shares for cash under 26 U.S.C. § 409(h).

Say what they do not receive: stock they can sell, a dividend they can spend, a board seat, or a vote on ordinary corporate matters. Voting passes through only on the major events specified in 26 U.S.C. § 409(e) — merger, sale of substantially all assets, liquidation, and similar.

Warn about the early years. In a leveraged transaction the shares sit in a suspense account and release as the loan is repaid. The first statements will show small balances in a company just valued in the tens of millions, and employees who were promised ownership will read that as a broken promise unless it was explained.

Warn that the valuation can fall. A leveraged company is worth less immediately after closing than before, because of the debt.

Then build the annual rhythm: a meeting presenting the valuation and what moved it; a plain-language plan summary alongside the required summary plan description; personalized statements with a projection; and a question channel that does not run through the seller.

And a caution for counsel: enthusiastic "ownership" messaging becomes an exhibit if the company later disappoints. Describe the plan accurately, describe the risks, and keep the materials.

Step 11 — Run the plan, and monitor the trustee

The appointing fiduciary's continuing duty is the one boards forget. Whoever appoints the trustee must monitor its performance — reviewing the annual valuation process, the appraiser's independence and competence, distribution administration, and the trustee's own governance. Boards appoint a trustee at closing and never revisit it, and that omission is a recurring source of liability.

Prudence is process, and it is continuing. Tibble v. Edison International, 575 U.S. 523 (2015) established that the duty to monitor is a distinct and continuing duty, and Hughes v. Northwestern University, 595 U.S. 170 (2022) reaffirmed that fiduciaries must monitor and remove imprudent investments rather than relying on the range of options offered.

The annual valuation is the recurring risk. It sets participant account balances and the repurchase price. Monitor the appraiser's independence, methodology, and consistency, and document the committee's review.

Manage the repurchase obligation deliberately. Refresh the study every two to three years. Choose between redeeming (company buys shares, share count falls, per-share value rises, next cohort's balances rise) and recycling (plan buys shares with contributions, share count constant). Both have consequences; drifting into one by default is how companies end up borrowing to pay retirees. Remember the diversification right under 26 U.S.C. § 401(a)(28)(B) accelerates part of the obligation.

And keep the governance map current as people change roles. The most common ESOP governance failure is a person acting as a fiduciary while thinking as an executive.

Step 5B — Handling the seller's expectations, which is most of the work

The technical steps in this guide are straightforward. The difficult part is that the seller has been told a number by someone with a fee at stake, and the fiduciary process is going to produce a different one.

Have the conversation in the first meeting. Explain that the price will be fair market value determined by an independent trustee, not the number in the pitch; that a strategic buyer would likely pay more; and that the trustee's duty runs to employees, not to the seller. Sellers who hear this at the outset accept the outcome. Sellers who hear it after the trustee's opening offer conclude they are being cheated.

Explain why the seller cannot control the process. The transaction is prohibited by 29 U.S.C. § 1106 and permitted only through the § 1108(e) exemption, whose condition is adequate consideration determined in good faith by the trustee. A seller who picks the trustee, picks the appraiser, or lobbies on value has destroyed the exemption's foundation — and the resulting exposure lands on the company the employees now own.

Reframe the fee objection. Sellers resent paying the trustee, its counsel, and its appraiser — the parties negotiating against them. The answer: those fees buy a defensible transaction, and a defect discovered later costs the company many multiples of the saving, out of the pockets of the employees the seller wanted to benefit.

Handle the specific pressure points in advance. The seller will want to call the appraiser; say no in writing before it happens. The seller will want to attend the trustee's diligence meetings; explain why not. The seller's advisor will want to send the trustee a valuation; explain that it may inform expectations and cannot support the determination.

And be prepared to lose the engagement. Some sellers want a controlled process and will find a professional who provides one. Counsel who agrees to that is participating in a transaction that will be unwound, at the expense of employees. Decline it, in writing, with the reason.

Step 6A — What the lender needs, and why that helps you

The senior lender is the one party in the transaction with no stake in the price and a professional interest in whether the debt can be repaid. Treat its analysis as free due diligence.

What a lender to an ESOP transaction looks at. Historical and projected cash flow with real sensitivity analysis; leverage and fixed charge coverage including the plan contributions, which are cash even though they are deductible under 26 U.S.C. § 404(a)(9); customer and supplier concentration; the depth of management after the seller departs; working capital swings; capital expenditure requirements; and the subordination terms of the seller note.

The covenants will shape the company for years. Fixed charge coverage, leverage ratios, minimum EBITDA, limits on capital expenditure, and — critically — limits on distributions and on the plan contributions themselves. A covenant package that constrains contributions constrains the rate at which shares are released to participants, which is a benefits consequence hiding in a credit agreement. Have benefits counsel read the covenants.

Subordination of the seller note is heavily negotiated: standstill periods, payment blockage on default, and whether the seller may accelerate. The seller should understand that in a downturn the note stops paying and there is nothing to be done about it.

Personal guarantees. Lenders sometimes ask the seller to guarantee, which sits awkwardly with a seller who has just exited. Resist, or bound it tightly in amount and duration.

Use the lender's skepticism. If the credit committee will not support the leverage the deal assumes, that is important information about feasibility, arriving from a party with no fee at stake. Companies that treat a lender's pushback as an obstacle to be shopped around are usually the ones that struggle in year four.

And build refinancing flexibility. Prepayment terms, the ability to refinance the senior facility as leverage falls, and the ability to restructure the internal loan — all easier to negotiate now than after a covenant breach.

Step 7A — Drafting the plan document

The transaction closes; the plan runs for decades on choices made in a document nobody rereads. A short list of the provisions that matter most.

Eligibility and entry. Statutory minimums under 26 U.S.C. § 401(a). Broader eligibility spreads the benefit and increases the repurchase obligation; narrower does the reverse. Decide deliberately.

Vesting. Faster vesting is a better employee benefit and accelerates the repurchase obligation. Model both effects.

Allocation formula. Usually compensation-based. Consider whether a cap on the compensation counted is appropriate, and how the formula interacts with § 409(p) if an S election is coming.

Distribution timing. The plan sets when distributions begin after separation, within statutory limits, and whether they may be paid in installments. This is the single most powerful lever on the repurchase obligation. Longer permissible deferral and installment payment smooth the cash requirement substantially; participants experience it as a delay in getting their money. Choose with the repurchase study in front of you.

Put option terms. Section 409(h) requires the put; the plan sets the mechanics within the permitted range, including installment payment with adequate security and a reasonable rate.

Recycling versus redemption. Whether repurchased shares return to the plan for reallocation or are retired by the company. This changes the share count, the per-share value, and who benefits — and it should be a documented policy rather than an accident of practice.

Diversification. The plan implements the § 401(a)(28)(B) right for qualified participants at 55 with ten years of participation, and the mechanics affect timing of cash out.

Voting pass-through. Section 409(e) requires it on the major events. The plan specifies the procedure and — importantly — what happens to allocated shares for which no direction is received.

Committee authority and indemnification, drafted against 29 U.S.C. § 1110, which voids exculpation but permits employer indemnification.

And a claims procedure that actually works, because participant disputes about account values and distributions are the ordinary litigation in these plans, and a well-run internal procedure resolves most of them.

Step 8A — Costs, timeline, and what to tell the seller up front

Sellers agree to an ESOP on an enthusiastic pitch and then experience the process as slow and expensive. Set the expectation in the first meeting.

Timeline. Twelve to eighteen months from serious consideration to closing is normal for a company of any complexity. Feasibility and team assembly take two to four months; trustee diligence and valuation four to six; negotiation one to three; documentation and closing two to three. A seller who needs liquidity in six months should be looking at a different transaction.

Costs. A mid-market leveraged ESOP carries several distinct fee streams: company counsel for plan design and corporate work; seller's counsel; trustee's fees plus its independent counsel and its appraiser — all of which the company pays, and which are the fees sellers find hardest to accept because they fund the party negotiating against them; a financial advisor and fairness opinion where used; lender fees; the feasibility study; and the initial repurchase obligation study. Aggregate transaction costs commonly run into the high six figures for a mid-market deal, and higher where the structure is complex.

Then the recurring costs, which nobody mentions in the pitch: annual independent appraisal, plan administration and recordkeeping, Form 5500 and testing, § 409(p) testing for S corporations, trustee fees, fiduciary insurance, periodic repurchase studies, and the committee's own time. Budget a meaningful annual number, permanently.

What the seller actually receives, and when. Usually a minority of the price in cash at closing, with the balance in a subordinated note amortizing over years — secured by nothing but the business the seller just sold, behind a bank. Model the seller's cash flow, and model what happens to it in the downturn case.

Say all of this in writing before the seller commits. A seller who understands the timeline, the fee load, the deferred liquidity, and the credit risk makes a sound decision. One who understands only the § 1042 deferral has been sold something.

Step 9A — How Thornbury Instrument's fourteen months ran

Months 1–2: feasibility, done first and done honestly. Three cases modeled. The downturn case, calibrated to the company's own 2008–2010 experience, supported $38 million with covenant headroom; management's plan implied $47 million. Thornbury-Vale had been told to expect the higher number by an advisor who would have earned a fee on it. Vandeleur-Achebe's first act was to commission an independent look, and it changed the whole transaction.

Month 2: the written comparison. Two pages to the seller comparing the ESOP against a strategic sale and a sponsor recapitalization, with the honest statement that a competitor with synergies would likely pay more. Thornbury-Vale signed it. That document has since answered the only question his family ever asked.

Months 3–4: the team. Institutional trustee appointed by the board with Thornbury-Vale recused. Trustee's counsel — a different firm with no history with the seller. Appraiser selected by the trustee through a documented process. Company counsel, seller's counsel, and trustee's counsel each with a written engagement stating whom they represent.

Months 4–7: diligence and valuation. Two findings moved the number: customer concentration at 44% rather than the 36% presented, and a five-year plan assuming 6.5% growth against a 2.4% ten-year history. Thornbury-Vale's instinct was to argue with the appraiser. He was told, correctly, that any such communication would become an exhibit.

Months 7–9: the negotiation. Trustee opened at $36 million against an expectation of $47 million. Three exchanges over seven weeks, with movement on both sides tied to specific diligence findings and to a restructured seller note. Closed at $41.5 million.

Months 9–11: structure. $16 million senior debt; $25.5 million seller notes at 5.5%; warrants for 17% of fully diluted equity — sized only after the § 409(p) analysis was run, because warrants are synthetic equity and the sequencing matters. C corporation status confirmed for closing; qualified replacement property strategy arranged with the seller's investment advisor before the closing date.

Month 11: closing, with the fiduciary role map, the fidelity bond under 29 U.S.C. § 1112, fiduciary liability coverage, and a repurchase obligation study all in place within thirty days.

Months 12–14: communication and setup. Four all-hands sessions explaining what participants would and would not receive, including the suspense account mechanics and the fact that the first valuation after closing would be lower because of the debt. S election effective the following year after built-in gains modeling.

Where it stands. Three years in, on schedule, with a valuation above the transaction price and 210 employees holding accounts they did not have.

The three things Vandeleur-Achebe says made the difference: the independent feasibility study before anyone set a price; a trustee and appraiser the seller did not choose; and a negotiation the file can prove. The $5.5 million the seller gave up is, in her words, "the premium on an insurance policy we have never had to claim."

Step 10A — Partial sales, second stages, and the eventual exit

Not every transaction is a 100% sale, and an ESOP is not necessarily permanent. Plan for the sequence.

The partial sale. Selling 30% — the § 1042 threshold — or 49% gives the seller liquidity and the deferral while keeping control and limiting the debt. The complications are real: the plan holds a minority stake, the valuation applies minority and marketability discounts, and the trustee is a fiduciary for a minority position in a company controlled by the person who sold it. Negotiate governance protections for the trustee — board representation, information rights, protective provisions on affiliate transactions and compensation — because a trustee accepting a minority position with no protections has a prudence problem.

The second-stage transaction. Many partial ESOPs are followed years later by a sale of the remaining shares. Stage two is an entirely new prohibited transaction requiring fresh adequate consideration analysis, a fresh trustee process, fresh diligence, and a fresh negotiation. It inherits nothing from stage one, and treating it as an administrative follow-on is the most common error in this sequence.

Selling the company later. An ESOP company can be sold, and the pass-through voting right in 26 U.S.C. § 409(e) becomes operative: participants direct the vote of allocated shares on a merger or sale of substantially all assets. The trustee votes unallocated shares and decides how to treat non-directed allocated shares under the plan's terms.

The trustee's posture on a sale is the mirror of the purchase. Its duty is to obtain no less than adequate consideration, which requires a real market check, independent valuation, independent counsel, and documented deliberation. It must also scrutinize anything diverting value from the plan — management transaction bonuses, rollover equity offered to executives, and the allocation of indemnity risk. A buyer's rich management incentives are a conflict the trustee manages, not ignores.

Termination without a sale means repurchasing every share at once, which is generally why it does not happen.

And the failure case. Where debt cannot be serviced, the restructuring involves lenders, the seller as subordinated creditor, and participants holding accounts in a company worth less than they were told. That is the fact pattern behind most of the litigation in this area, and it traces almost invariably back to Step 1.

Step 11A — Governance of an ESOP-owned company

An ESOP company has a board, a trustee, a plan committee, and a management team, with overlapping membership and genuinely different duties. Getting the architecture right at closing prevents most of what goes wrong later.

The board runs the company and owes ordinary corporate fiduciary duties to the corporation and its shareholder — which is now the plan. It also, wearing a different hat, serves as appointing fiduciary for the trustee, which is an ERISA role.

The trustee is the shareholder. It votes the shares (subject to pass-through on the events specified in 26 U.S.C. § 409(e)), elects directors in most structures, and owes its duties under 29 U.S.C. § 1104 solely to participants.

The plan committee administers the plan — eligibility, allocations, distributions, participant communications — and is a fiduciary for those functions.

Management runs the business and is not a fiduciary in that capacity, though the same individuals frequently sit on the committee or the board.

Design decisions worth making deliberately:

Independent directors. An ESOP company has no controlling shareholder to intervene, which makes genuinely independent directors more valuable here than in most private companies. Two or three, with real industry or financial expertise, is the usual answer.

Who the trustee is post-closing. Many companies replace the transaction trustee with a less expensive ongoing trustee — sometimes an internal committee. That is permissible and it shifts fiduciary exposure onto employees of the company. Do it knowingly, with insurance and training.

Information flow to the trustee. The trustee needs financial statements, board materials, and notice of major developments to discharge its duties. Put a protocol in place rather than leaving it to relationships.

Conflict protocols. When a director who is also an executive participates in a decision about executive compensation, or a committee member decides on the distribution of his own account, the recusal rule should already exist in writing.

And the annual hat-check. Once a year, circulate the role map and ask each person to confirm which capacities they hold. It takes an hour and it is the single best defense against the most common governance failure in these companies.

Step 12 — If the government calls

The Department of Labor has treated ESOP valuation as an enforcement priority for years, and its theory is consistent: the plan paid more than adequate consideration, so the § 1108(e) exemption fails, so the transaction was a prohibited transaction under § 1106, and the fiduciaries are liable under § 1109 for the overpayment plus lost earnings — with excise tax exposure for parties in interest under 26 U.S.C. § 4975.

Engage ERISA counsel immediately, and separately for the company, the trustee, and the seller, whose interests diverge.

Produce the process file. Trustee selection, appraiser selection and engagement, diligence materials, projection testing, negotiation history, deliberative minutes, and the fairness opinion. The substantive question — was the price right — is contested by experts years later; the process question is answered by documents created contemporaneously or not at all.

Expect the questions to track the enforcement pattern: who selected the appraiser and who paid it; what relationships existed between the trustee and the seller; whether the projections were tested; whether anyone negotiated; how warrants were valued; and whether the company could service the debt.

And the lesson for the next transaction. Everything above in Steps 3 through 6 exists to make this conversation short. A file that shows an independent trustee, an independently selected appraiser, tested projections, and a real negotiation is a file that ends the inquiry. One that shows a valuation report and a signature page is the start of a decade.